William J. Newell
Net Worth

Last updated:

What is William J. Newell net worth?

The estimated net worth of Mr. William J. Newell is at least $5,458,628 as of 5 Mar 2024. He owns shares worth $100,328 as insider and has received compensation worth at least $5,358,300 in Sutro Biopharma, Inc..

What is the salary of William J. Newell?

Mr. William J. Newell salary is $893,050 per year as Chief Executive Officer & Director in Sutro Biopharma, Inc..

How old is William J. Newell?

Mr. William J. Newell is 67 years old, born in 1958.

What stocks does William J. Newell currently own?

As insider, Mr. William J. Newell owns shares in one company:

Company Title Shares Price per share Total value
Sutro Biopharma, Inc. (STRO) Chief Executive Officer & Director 116,525 $0.86 $100,328

What does Sutro Biopharma, Inc. do?

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO logo
STRO
Sutro Biopharma, Inc.
$0.86

William J. Newell insider trading

Sutro Biopharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 18,750 N/A N/A
Option
Restricted Stock Unit (RSU) 18,750 N/A N/A
Option
Common Stock 31,125 N/A N/A
Option
Restricted Stock Unit (RSU) 31,125 N/A N/A
Option
Common Stock 23,750 N/A N/A
Option
Restricted Stock Unit (RSU) 23,750 N/A N/A
Option
Restricted Stock Unit (RSU) 13,750 N/A N/A
Option
Common Stock 13,750 N/A N/A
Option
Common Stock 31,125 N/A N/A
Option
Common Stock 18,750 N/A N/A
Option
Restricted Stock Unit (RSU) 18,750 N/A N/A
Option
Restricted Stock Unit (RSU) 31,125 N/A N/A
Option
Restricted Stock Unit (RSU) 13,750 N/A N/A
Option
Common Stock 13,750 N/A N/A
Purchase
Common Stock 10,000 $7.75 $77,510
Option
Common Stock 18,750 N/A N/A
Option
Restricted Stock Unit (RSU) 18,750 N/A N/A
Option
Common Stock 13,750 N/A N/A
Option
Restricted Stock Unit (RSU) 13,750 N/A N/A
Option
Restricted Stock Unit (RSU) 25,253 N/A N/A
Option
Common Stock 25,253 N/A N/A
Option
Common Stock 13,750 N/A N/A
Option
Restricted Stock Unit (RSU) 13,750 N/A N/A
Option
Restricted Stock Unit (RSU) 25,252 N/A N/A
Option
Common Stock 25,252 N/A N/A
Purchase
Common Stock 64,516 N/A N/A
Option
Restricted Stock Unit (RSU) 25,252 N/A N/A
Option
Common Stock 25,252 N/A N/A

Sutro Biopharma key executives

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC: